European Journal of Clinical Pharmacology

, Volume 62, Issue 5, pp 343–346 | Cite as

Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands

  • T. W. de VriesEmail author
  • J. J. de Langen-Wouterse
  • E. van Puijenbroek
  • E. J. Duiverman
  • L. T. W. de Jong-Van den Berg



Inhaled corticosteroids (ICS) are widely used in the treatment of asthma. We studied the suspected adverse drug reactions (sADRs) reported during the use of ICS in the Netherlands.


In the Netherlands, health professionals and patients can report suspected ADRs to the Pharmacovigilance Centre Lareb. All reported sADRs on ICS were categorised and assessed as to whether these were likely to be associated with use of the steroid. Age and gender adjusted Reported Odds Ratios (RORs) and Naranjo Scores (NS) were computed for sADRs reported more than 3 times.


Since 1984, sADRs of ICS were reported in 89 children (mean age 6 years), 48 (54%) were boys. Suspected drugs were fluticasone in 46 children (52%), budesonide in 21 (24%), and beclomethasone in 22 cases (24%). Psychiatric symptoms were reported in 19 children (21%; ROR 3.8, NS 3.6), growth retardation in 6 children (7%; ROR 47.8, NS 3.0) and rashes in 6 cases (7%; ROR 0.7, NS 2.4). There were 7 reports (8%; ROR 2.1, NS 3.4) concerning abnormalities of the teeth, 4 reports of alopecia (4%; ROR 3.3, NS 3.5), and 3 reports of hirsutism and hypertrichosis (NS 4.0). Non-fatal adrenal insufficiency was reported once.


Alteration of behaviour was the most frequently reported sADR. There are more indications that alterations of behaviour could be a real sADR of ICS. Non-fatal adrenal insufficiency was the only reported possible life threatening sADR. The association of hypertrichosis and teeth abnormalities after ICS in children has not been reported in the literature before.


Inhaled corticosteroids Naranjo scores Reported odds ratios Suspected adverse drug reactions 



We thank Dr. J. Collins for reviewing the English.


  1. 1.
    Agertoft L, Pedersen S (2000) Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 343:1064–1069PubMedCrossRefGoogle Scholar
  2. 2.
    Anonymous (1997) Asthma in adults and schoolchildren. The General Practitioner in Asthma Group, the British Association of Accident and Emergency Medicine, The British Paediatric Respiratory Society and the Royal College of Paediatrics and Child Health. Thorax 52(suppl 1):s2–s8Google Scholar
  3. 3.
    Anonymous (1997) Asthma in children under five years of age. The General Practitioner in Asthma Group, the British Association of Accident and Emergency Medicine, The British Paediatric Respiratory Society and the Royal College of Paediatrics and Child Health. Thorax 52(suppl 1):s9–s20Google Scholar
  4. 4.
    Anonymous (2000) Corticotrophins and corticosteroids. In: Dukes MGN, Aronson JK (eds) Meyler’s side effects of drugs. Elsevier, Amsterdam pp 1369–1389Google Scholar
  5. 5.
    Anonymous (2003) Review of systemic adverse effects associated with corticosteroids
  6. 6.
    Bender BC, Ikle DN, DuHamel T, Tinkelman D (1998) Neuropsychological and behavioral changes in asthmatic children treated with beclomethasone dipropionate versus theophylline. Pediatrics 101:355–360PubMedCrossRefGoogle Scholar
  7. 7.
    Calam R, Gregg L, Simpson A, Simpson B, Woodcock A, Custovic A (2005) Behavior problems antecede the development of wheeze in childhood. Am J Respir Crit Care Med 171:323–327PubMedCrossRefGoogle Scholar
  8. 8.
    Clarkson A, Choonara I (2002) Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Childhd 87:462–466CrossRefGoogle Scholar
  9. 9.
    Dubus JC, Marguet C, Deschildere A, Mely L, Le Roux P, Brouard J, Huiart L (2001) Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device. Allergy 56:944–948PubMedCrossRefGoogle Scholar
  10. 10.
    Elias PC, Sagua D, Alvarez EO (2004) Chronic aerial exposure to glucosteroids or beta-agonists affects avoidance learning and exploratory motivation in rats. Behav Brain Res 149:95–105PubMedCrossRefGoogle Scholar
  11. 11.
    Global Initiative for Asthma (GINA) (2002) Global strategy for asthma management and prevention. National Institutes of Health. National Heart, Lung, and Blood Institute. Bethesda, Md., USAGoogle Scholar
  12. 12.
    Hadjikoumi I, Loader P, Bracken M, Milner AD (2004) Bronchodilator therapy and hyperactivity in preschool children. Arch Dis Childhood 86:202–203CrossRefGoogle Scholar
  13. 13.
    Hanania NA, Chapman KR, Kesten S (1995) Adverse effects of inhaled corticosteroids. Am J Med 98:196–208PubMedCrossRefGoogle Scholar
  14. 14.
    Hederos C (2004) Neuropsychologic changes and inhaled steroids. J Allergy Clin Immunol 114:451–452PubMedCrossRefGoogle Scholar
  15. 15.
    Kayani S, Shannon DC (2002) Adverse behavioral effects of treatment for acute exacerbation of asthma in children. Chest 122:624–628PubMedCrossRefGoogle Scholar
  16. 16.
    Lipworth BJ (1999) Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 159:941–955PubMedCrossRefGoogle Scholar
  17. 17.
    Mak VHF, Melchor R, Spiro SG (1992) Easy bruising as a side effect of inhaled corticosteroids. Eur Respir J 5:1068–1074PubMedGoogle Scholar
  18. 18.
    McQuaid EL, Kopel SJ, Nassau JH (2001) Behavioral adjustment in children with asthma: a meta-analysis. J Dev Behav Pediatr 22:430–439PubMedGoogle Scholar
  19. 19.
    Meyboom RH, de Graaf-Breederveld N (1988) Budesonide and psychic side effects. Ann Intern Med 109:683PubMedGoogle Scholar
  20. 20.
    Meyboom RH, Verduijn MM, Steenvoorden MG, Dekens-Konter JA, van Puijenbroek EP (1996) Reversible tooth discoloration during oral use of antibiotics. Ned Tijdschr Geneeskd 140:207–209PubMedGoogle Scholar
  21. 21.
    Moore N, Kreft-Jais C, Haramburu F, Noblet C, Andrejak M, Ollagnier M, Begaud B (1997) Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol 44:513–518PubMedCrossRefGoogle Scholar
  22. 22.
    Naranjo CA, Busto U, Sellers, EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq, Greenblatt DJ (1981) A method for estimating the probability of adverse effects. Clin Pharmacol Ther 30:239–245PubMedCrossRefGoogle Scholar
  23. 23.
    Todd GRC, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D (2002) Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 87:457–461PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • T. W. de Vries
    • 1
    Email author
  • J. J. de Langen-Wouterse
    • 2
  • E. van Puijenbroek
    • 2
  • E. J. Duiverman
    • 3
  • L. T. W. de Jong-Van den Berg
    • 4
  1. 1.Department of PediatricsMedical Centre LeeuwardenLeeuwardenThe Netherlands
  2. 2.Netherlands Pharmacovigilance Centre Lareb’s-HertogenboschThe Netherlands
  3. 3.Department of Paediatric PulmonologyUniversity HospitalGroningenThe Netherlands
  4. 4.Department of Social Pharmacy, Pharmacoepidemiology and PharmacotherapyGroningen University Institute for Drug ExplorationGroningenThe Netherlands

Personalised recommendations